Trudy Oliver, PhD, studies a type of cancer that has a 5-year overall survival rate of just 7%. Its biological drivers are different from most other cancers, so it’s harder to develop targeted treatments. On top of that, research into this tumor is under-funded.

David Ashley, PhD, FRACP, MBBS, the Rory David Deutsch Distinguished Professor of Neuro-Oncology and director of the Preston Robert Tisch Brain Tumor Center at Duke, calls his choice to focus his c

Dean Mary Klotman, MD, welcomes Barbara Hooper, the Founding Program Director and Division Chief of the Occupational Therapy Doctorate Program at Duke. They discuss the division's goals and some of the misconceptions about Occupational Therapy, and about what sets Duke’s program apart.

Home visiting programs have been shown to reduce emergency room visits, hospitalizations, and overall health care costs for patients with complex needs.

The Dean’s Staff Awards will be awarded annually to recognize exemplary staff supporting the School of Medicine’s mission and values.

Black patients at risk for sudden cardiac arrest have historically been less likely to receive potentially life-saving implantable cardioverter defibrillators (ICD) than white patients.

Len White's pioneering Coursera online course in neuroscience has changed lives around the world.

Colin Duckett, Vice Dean for Basic Science, led a discussion with premier researchers taking a a closer look at the fundamental biology of Parkinson’s disease during the March 30 Dean’s Distinguished Research Series.

A national committee co-chaired by Duke Professor Charmaine Royal issued a report that emphasized the high stakes of ensuring that genetics research benefits all groups in society and mitigates harm.

A Duke infectious disease researcher explains why public health officials are closely watching a virus that some say could cause the next pandemic.